172932-06-8

Basic information

• Product Name: 4-(2-nitrophenoxy)benzaldehyde
• Synonyms: 4-(2-nitrophenoxy)benzaldehyde
• CAS NO: 172932-06-8
• Molecular Weight: 243.219
• Mol File: 172932-06-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(2-nitrophenoxy)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-nitrophenoxy)benzaldehyde(172932-06-8)
• EPA Substance Registry System: 4-(2-nitrophenoxy)benzaldehyde(172932-06-8)

Safety Data

• Hazardous Substances Data: 172932-06-8(Hazardous Substances Data)

Upstream product

• 101-84-8 diphenylether 
• 123-08-0 4-hydroxy-benzaldehyde 
• 1493-27-2 ortho-nitrofluorobenzene 
• 459-57-4 4-fluorobenzaldehyde 
• 88-75-5 2-hydroxynitrobenzene 
• 67-36-7 4-phenoxy benzaldehyde 
• 88-73-3 2-Chloronitrobenzene 

Downstream Products

• 1596272-14-8 methyl 2-(hydroxy(4-(2-nitrophenoxy)phenyl)methyl)acrylate 
• 1596272-65-9 (E)-methyl 3-(4-(2-((E)-2-(4-chlorophenyl)-3-(4-(7-chloroquinolin-4-ylamino)butyl)guanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-63-7 (E)-methyl 3-(4-(2-((E)-2-(4-chlorophenyl)-3-(3-(7-chloroquinolin-4-ylamino)propyl)guanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-61-5 (E)-methyl 3-(4-(2-((E)-2-(4-chlorophenyl)-3-(2-(7-chloroquinolin-4-ylamino)ethyl)guanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-60-4 (E)-methyl 3-(4-(2-((E)-2-(3-chlorophenyl)-3-cyclopropylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-59-1 (E)-methyl 3-(4-(2-((E)-3-benzyl-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-56-8 (E)-methyl 3-(4-(2-((E)-2-(3-chlorophenyl)-3-(4-(7-chloroquinolin-4-ylamino)butyl)guanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-53-5 (E)-methyl 3-(4-(2-((E)-3-(3-(6-chloronaphthalen-1-ylamino)propyl)-2-(3-chlorophenyl)guanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-52-4 (E)-methyl3-{4-[2-((E)-3-(2-(6-chloronaphthalen-1-ylamino)ethyl)-2-(3-chlorophenyl)guanidino)phenoxy]phenyl}-2-methylacrylate 
• 1596272-51-3 (E)-methyl 3-(4-(2-((E)-3-cyclopropyl-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-50-2 (E)-methyl 3-(4-(2-((E)-3-benzyl-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-48-8 (E)-methyl 3-(4-(2-((E)-3-(4-(7-chloroquinolin-4-ylamino)butyl)-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-45-5 (E)-methyl 3-(4-(2-((E)-3-(3-(7-chloroquinolin-4-ylamino)propyl)-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 
• 1596272-43-3 (E)-methyl 3-(4-(2-((E)-3-(2-(7-chloroquinolin-4-ylamino)ethyl)-2-phenylguanidino)phenoxy)phenyl)-2-methylacrylate 

Relevant articles and documents

Importance of the proximity and orientation of ligand-linkage to the design of cinnamate-GW9662 hybrid compounds as covalent PPAR agonists

Covalent agonists of PPAR cause unique receptor conformational changes and behave as selective PPAR modulators, whereas there are few covalent agonists other than endogenous unsaturated fatty acids metabolites. Previously, we established a cell-based stra

Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid

A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.